|
CNOT4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.561300E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.949800E-01 |
| Normal-vs-Stage2 |
1.007750E-01 |
| Normal-vs-Stage3 |
1.241970E-04 |
| Normal-vs-Stage4 |
2.08269999999455E-05 |
| Stage1-vs-Stage2 |
1.477830E-01 |
| Stage1-vs-Stage3 |
2.406000E-04 |
| Stage1-vs-Stage4 |
2.06589999999229E-05 |
| Stage2-vs-Stage3 |
2.253000E-01 |
| Stage2-vs-Stage4 |
9.256400E-02 |
| Stage3-vs-Stage4 |
5.230800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.880000E-02 |
| Normal-vs-AfricanAmerican |
8.34090000000343E-05 |
| Normal-vs-Asian |
4.963600E-01 |
| Caucasian-vs-AfricanAmerican |
4.616900E-03 |
| Caucasian-vs-Asian |
2.897800E-01 |
| AfricanAmerican-vs-Asian |
3.168000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.257000E-03 |
| Normal-vs-Female |
1.325440E-01 |
| Male-vs-Female |
2.113600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.899200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.613210E-01 |
| Normal-vs-Age(61-80Yrs) |
3.400300E-03 |
| Normal-vs-Age(81-100Yrs) |
5.581400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.068400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.432200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.396440E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.066800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.205700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.916400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.537180E-01 |
| Normal-vs-Grade 2 |
5.982000E-01 |
| Normal-vs-Grade 3 |
1.980250E-03 |
| Normal-vs-Grade 4 |
7.29879999994409E-07 |
| Grade 1-vs-Grade 2 |
2.197400E-01 |
| Grade 1-vs-Grade 3 |
1.917580E-02 |
| Grade 1-vs-Grade 4 |
4.411400E-04 |
| Grade 2-vs-Grade 3 |
5.564800E-03 |
| Grade 2-vs-Grade 4 |
1.60062999999822E-05 |
| Grade 3-vs-Grade 4 |
1.007780E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.515400E-01 |
| Normal-vs-ccB subtype |
2.335300E-03 |
| ccA subtype-vs-ccB subtype |
1.54141999999524E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.776100E-02 |
| Normal-vs-N1 |
1.199430E-01 |
| N0-vs-N1 |
2.851200E-01 |
|
|
